Table 1:
Baseline Demographics
| Ganciclovir (n=52) | Foscarnet (n=12) | P value | |
|---|---|---|---|
| Median Age | 55.5 (9 to 73) | 53 (22 to 66) | 0.63 |
| Male | 33 (63%) | 10 (83%) | 0.31 |
| Underlying Condition | 0.27 | ||
| Leukemias | 34 (65%) | 5 (42%) | |
| Myelodysplastic Syndrome | 5 (10%) | 1 (8%) | |
| Lymphomas | 4 (8%) | 3 (25%) | |
| Multiple Myeloma | 1 (2%) | 0 (0%) | |
| Other | 8 (15%) | 3 (25%) | |
| Type of Transplant | 0.21 | ||
| Matched Related Donor | 7 (14%) | 4 (33%) | |
| Matched Unrelated Donor | 21 (40%) | 3 (25%) | |
| Haploidentical | 17 (32%) | 2 (17%) | |
| Cord Blood | 7 (14%) | 3 (25%) | |
| Myeloablative Conditioning | 23 (44%) | 7 (58%) | 0.52 |
| CMV Serostatus (Donor/Recipient) | 1.00 | ||
| +/+ | 28 (54%) | 6 (50%) | |
| +/− | 0 (0%) | 0 (0%) | |
| −/+ | 24 (46%) | 5 (42%) | |
| −/− | 0 (0%) | 0 (0%) | |
| Acute GVHD | 31 (60%) | 7 (58%) | 1.00 |
| Chronic GVHD | 8 (15%) | 1 (8%) | 1.00 |
| White Blood Cell Count (k/uL) | 5.2 (<0.1 to 15.6) | 1.8 (<0.1 to 3.9) | <0.05 |
| Absolute Neutrophil Count (k/uL) | 3.3 (<0.1 to 11.9) | 1.1 (<0.1 to 3.5) | <0.05 |